creatine has been researched along with Prostatic Hyperplasia in 11 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The (choline + creatine)/ citrate values in regions of histologically confirmed benign prostatic hyperplasia (0." | 3.69 | Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. ( Carroll, PR; Hricak, H; Kurhanewicz, J; Nelson, SJ; Parivar, F; Shinohara, K; Vigneron, DB, 1996) |
| "An estimate of the spatial extent of prostate cancer was determined by generating metabolite images in which this metabolite ratio significantly exceeded normal peripheral zone values in multiple contiguous sections." | 1.29 | Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. ( Carroll, P; Hricak, H; Kurhanewicz, J; Narayan, P; Nelson, SJ; Vigneron, DB, 1996) |
| "Seven patients were diagnosed with prostate cancer, 13 with benign prostatic hypertrophy, and 3 with both conditions." | 1.28 | Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR. ( Dalrymple, GV; Finkbeiner, AE; Fowler, AH; Holder, JC; Komoroski, RA; Mullins, MS; Pappas, AA; Sprigg, JR, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yue, K | 1 |
| Marumoto, A | 1 |
| Binesh, N | 1 |
| Thomas, MA | 1 |
| BRADLOW, HL | 1 |
| FUKUSHIMA, DK | 1 |
| GALLAGHER, TF | 1 |
| HELLMAN, L | 1 |
| HOFMANN, K | 1 |
| LI, CH | 1 |
| ROSENFELD, RS | 1 |
| SPENCER, H | 1 |
| ZUMOFF, B | 1 |
| MARMORSTON, J | 1 |
| LOMBARDO, LJ | 1 |
| MYERS, SM | 1 |
| GIERSON, H | 1 |
| STERN, E | 1 |
| HOPKINS, CE | 1 |
| Kumar, R | 1 |
| Kumar, M | 1 |
| Jagannathan, NR | 1 |
| Gupta, NP | 1 |
| Hemal, AK | 1 |
| Kurhanewicz, J | 2 |
| Vigneron, DB | 2 |
| Hricak, H | 2 |
| Narayan, P | 1 |
| Carroll, P | 1 |
| Nelson, SJ | 2 |
| Parivar, F | 1 |
| Shinohara, K | 1 |
| Carroll, PR | 1 |
| García-Segura, JM | 1 |
| Sánchez-Chapado, M | 1 |
| Ibarburen, C | 1 |
| Viaño, J | 1 |
| Angulo, JC | 1 |
| González, J | 1 |
| Rodríguez-Vallejo, JM | 1 |
| Stanka, M | 1 |
| Eltze, E | 1 |
| Semjonow, A | 1 |
| Sievert, KD | 1 |
| Maier, A | 1 |
| Pfleiderer, B | 1 |
| Kramhoft, J | 1 |
| Kronborg, O | 1 |
| Backer, OG | 1 |
| Sprechler, M | 1 |
| Fowler, AH | 1 |
| Pappas, AA | 1 |
| Holder, JC | 1 |
| Finkbeiner, AE | 1 |
| Dalrymple, GV | 1 |
| Mullins, MS | 1 |
| Sprigg, JR | 1 |
| Komoroski, RA | 1 |
| Alfthan, OS | 1 |
| Rusk, J | 1 |
| Tallgren, LG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study[NCT00061347] | Phase 1 | 15 participants (Actual) | Interventional | 2003-05-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 other studies available for creatine and Prostatic Hyperplasia
| Article | Year |
|---|---|
2D JPRESS of human prostates using an endorectal receiver coil.
Topics: Adult; Biomarkers, Tumor; Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Spectroscopy; M | 2002 |
ADRENAL STIMULATION BY ADRENOCORTICOTROPIC PEPTIDES.
Topics: Adrenocorticotropic Hormone; Carbon Isotopes; Chromatography; Creatine; Creatinine; Humans; Hydrocor | 1963 |
URINARY EXCRETION OF NEUTRAL 17-KETOSTEROIDS AND PREGNANEDIOL BY PATIENTS WITH PROSTATIC CANCER AND BENIGN PROSTATIC HYPERTROPHY.
Topics: 17-Ketosteroids; Androsterone; Blood Glucose; Blood Urea Nitrogen; Creatine; Creatinine; Etiocholano | 1965 |
Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Choline; Citric Acid; Creatine; Diagnosis, Differential; | 2004 |
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Topics: Adenocarcinoma; Adult; Aged; Choline; Citrates; Citric Acid; Creatine; Diagnosis, Differential; Huma | 1996 |
Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.
Topics: Aged; Choline; Citrates; Citric Acid; Creatine; Cryosurgery; Humans; Magnetic Resonance Imaging; Mag | 1996 |
In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
Topics: Aged; Aged, 80 and over; Choline; Citric Acid; Creatine; Diagnosis, Differential; Humans; Inositol; | 1999 |
[Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results].
Topics: Aged; Choline; Citrates; Creatine; Diagnosis, Differential; Humans; Magnetic Resonance Spectroscopy; | 2000 |
Urologic complications after operations for anorectal cancer, with an evaluation of preoperative intravenous pyelography.
Topics: Anus Neoplasms; Colostomy; Creatine; Female; Humans; Kidney Diseases; Male; Palliative Care; Postope | 1975 |
Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR.
Topics: Alanine; Citrates; Creatine; Glutamates; Glutamic Acid; Humans; In Vitro Techniques; Magnetic Resona | 1992 |
Renal function in prostatic hyperplasia.
Topics: Catheterization; Creatine; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Organ Si | 1965 |